Medicalsystem Biotechnology Co.,Ltd.’s Net Profit Rose 7.9% in 2022

Medicalsystem Biotechnology Co.,Ltd. (美康生物科技股份有限公司) (300439.SZ) reported a net profit of 205.2 million yuan in 2022, up 7.9% year-on-year.

Meanwhile, the company posted 2.5 billion yuan in revenue, up 10.6% year-on-year.

At the end of the reporting period, it had 3.6 billion yuan in total assets and 1.1 billion yuan in total liabilities, with a liability-to-asset ratio of 29.7%.